These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 7259841
21. Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of factor IX or fresh frozen plasma (FFP). Zauber NP, Levin J. Medicine (Baltimore); 1977 May; 56(3):213-24. PubMed ID: 859444 [Abstract] [Full Text] [Related]
27. Analysis of IgG heavy chain subclasses of alloantibodies to factor IX by crossed immunoelectrophoresis of factor IX using the intermediate gel technique. Iizuka A, Nagao T. Br J Haematol; 1983 Apr; 53(4):687-8. PubMed ID: 6403026 [No Abstract] [Full Text] [Related]
28. Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates. Kim HC, McMillan CW, White GC, Bergman GE, Horton MW, Saidi P. Blood; 1992 Feb 01; 79(3):568-75. PubMed ID: 1531035 [Abstract] [Full Text] [Related]
35. Prednisolone treatment induced temporary factor IX normalization in mild hemophilia B who required an epidural infiltration: A case report. Carrette M, Feugray G, Chamouni P, Le Cam Duchez V, Fretigny M, Barbay V, Billoir P. Transfus Apher Sci; 2019 Aug 01; 58(4):512-514. PubMed ID: 31272859 [Abstract] [Full Text] [Related]
36. Comparison of precipitating antisera against normal and abnormal factor IX. Orstavik KH. Thromb Res; 1977 May 01; 10(5):731-41. PubMed ID: 407667 [No Abstract] [Full Text] [Related]
37. Kinetics of factor IX activity differ from that of factor IX antigen in patients with haemophilia B receiving high-purity factor IX replacement. Liebman HA, Rosenwald-Zuckerman T, Retzios A, Yasmin S, Kasper CK. Haemophilia; 1999 May 01; 5(3):174-80. PubMed ID: 10444284 [Abstract] [Full Text] [Related]
40. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX. Bajaj SP, Rapaport SI, Russell WA. Biochemistry; 1983 Aug 16; 22(17):4047-53. PubMed ID: 6604546 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]